For some cancer patients, a “poop transplant” could boost the positive effects of immunotherapy, a treatment designed to rally the immune system against cancer cells.
Not all cancer patients respond to immunotherapy
drugs.
For example, only about 40% of patients with advanced melanoma,
a type of skin cancer, reap long-term benefit from the drugs, according to recent
estimates.
In trying to pinpoint the differences between patients who respond well to immunotherapy and those who don’t, scientists…
